Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

T2Candida panel offers survival, cost savings benefits
June 2015
by  |  Email the author
EDIT CONNECT

SHARING OPTIONS:

LEXINGTON, Mass.—A study conducted by IMS Health of T2 Biosystems Inc.’s T2Candida Panel was recently published in Future Microbiology. The study reported that in a 500-bed hospital with an average of 5,100 symptomatic patients at high risk of Candida infection, early detection—such as with T2Candida—could prevent 60 percent of Candida-related deaths and provide annual cost savings of approximately $5.8 million.
 
“We believe these data are extremely compelling and highlight the potentially meaningful benefits of early detection of Candida with our T2Candida Panel, including significantly reducing hospital costs and, more importantly, saving so many patient lives,” said T2 Biosystems CEO John McDonough. “The findings from this study support our goal of changing the paradigm in sepsis diagnosis, and we look forward to the opportunity to help implement this important change for patients, physicians and hospital administrators.”
 
Code:

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.